Crossref
journal-article
Springer Science and Business Media LLC
Nature Biotechnology (297)
References
46
Referenced
45
-
Detjen, B.M., St. Angelo, C. Katze, M.G. & Krug, R.M. The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J. Virol. 61, 16–22 (1987).
(
10.1128/JVI.61.1.16-22.1987
) / J. Virol. by BM Detjen (1987) -
Nakagawa, Y. The RNA polymerase PB2 subunits is not required for replication of the influenza virus genome but is involved in capped mRNA synthesis. J. Virol. 69, 728–733 (1995).
(
10.1128/JVI.69.2.728-733.1995
) -
Sanz-Ezquerro, J.J., de la Luna, S., Ortin, J. & Nieto, A. Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J. Virol. 69, 2420–2426 (1995).
(
10.1128/JVI.69.4.2420-2426.1995
) / J. Virol. by JJ Sanz-Ezquerro (1995) - Rothenberg, M. et al. Oligodeoxynucleotides as antisense inhibitor of gene expression: therapeutic implications. J. Natl. Cancer. Inst. 81, 1538–1544 (1989). / J. Natl. Cancer. Inst. by M Rothenberg (1989)
-
Zamecnik, P.C. & Stephenson, M.L. Inhibition of Rous sarcoma virus replication and transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 75, 280–284 (1978).
(
10.1073/pnas.75.1.280
) / Proc. Natl. Acad. Sci. USA by PC Zamecnik (1978) -
Zamecnik, P.C., Goodchild, J., Taguchi, Y. & Sarin, P.S. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic immunodeficiency oligonucleotides complementary to viral RNA. Proc. Natl. Acad. Sci. USA 83, 4143–4146 (1986).
(
10.1073/pnas.83.12.4143
) / Proc. Natl. Acad. Sci. USA by PC Zamecnik (1986) -
Miller, P.S. et al. Control ribonucleic acid function by oligonucleotide methylphosphonates. Biochimie 67, 769–776 (1985).
(
10.1016/S0300-9084(85)80166-8
) / Biochimie by PS Miller (1985) -
Smith, C.C., Aurelian, L., Reddy, M.P., Miller, P.S. & Ts'o, P.O.P. Antiviral effect of an oligo (nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc. Natl. Acad. Sci. USA 83, 2787–2791 (1986).
(
10.1073/pnas.83.9.2787
) / Proc. Natl. Acad. Sci. USA by CC Smith (1986) -
Matsukura, M. et al. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84, 7706–7710 (1987).
(
10.1073/pnas.84.21.7706
) / Proc. Natl. Acad. Sci. USA by M Matsukura (1987) -
Zerial, A., Thuong, N.T. & Hélène, C. Selective inhibition of the cytopathic effect of type A influenza virus by oligonucleotides covalently linked to an intercalating agent. Nucleic Acids Res. 15, 9909–9919 (1987).
(
10.1093/nar/15.23.9909
) / Nucleic Acids Res. by A Zerial (1987) -
Leiter, J.M.E., Agrawal, S., Palese, P. & Zamecnik, P.C. Inhibition of influenza virus replication by phosphorothioate oligonucleotides. Proc. Natl. Acad. Sci. USA 87, 3430–3434 (1990).
(
10.1073/pnas.87.9.3430
) / Proc. Natl. Acad. Sci. USA by JME Leiter (1990) -
Kim, S-G. et al. Anti-HIV activities and physicochemical properties of phosphorothioate analogues complementary to HIV sequences. Bioorg. Med. Chem. Lett. 3, 1223–1228 (1993).
(
10.1016/S0960-894X(00)80320-0
) / Bioorg. Med. Chem. Lett. by S-G Kim (1993) -
Kim, S-G. et al. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus. Bioorg. Med. Chem. Lett. 3, 49–54 (1995).
(
10.1016/0968-0896(94)00142-P
) / Bioorg. Med. Chem. Lett. by S-G Kim (1995) -
Whitesell, L., Rosolen, A. & Neckers, L.M. In vitro modulation of N-myc expression by continuous perfusion with an antisense oligonucleotide. Antisense Res. Dev. 1, 343–350 (1991).
(
10.1089/ard.1991.1.343
) / Antisense Res. Dev. by L Whitesell (1991) -
Simons, M., Edelman, E.R., DeKeyser, J-L., Langer, R. & Rosenberg, R.D. Antisense c- myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo. Nature 359, 67–70 (1992).
(
10.1038/359067a0
) / Nature by M Simons (1992) -
Skorski, T. et al. Suppression of Philadelphia leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 91, 4504–4508 (1994).
(
10.1073/pnas.91.10.4504
) / Proc. Natl. Acad. Sci. USA by T Skorski (1994) -
Hélène, C. & Toulmé, J.J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta 149, 99–125 (1990).
(
10.1016/0167-4781(90)90031-V
) / Biochim. Biophys. Acta by C Hélène (1990) - Erickson, R.P. & Yzant, J.G. Gene regulation, biology of antisense RNA and DNA (Raven, London; 1992). / Gene regulation, biology of antisense RNA and DNA by RP Erickson (1992)
-
Miller, P.S., Mc Parland, K.B., Yayaraman, N. & Ts'o, P.O.P. Biochemical and biological effects of nonionic nucleic acid methylphosphonates. Biochemistry 20, 1874–1880 (1981).
(
10.1021/bi00510a024
) / Biochemistry by PS Miller (1981) -
Stec, W., Zon, G., Egan, W. & Stec, B. Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides. J. Am. Chem. Soc. 106, 6077–6079 (1984).
(
10.1021/ja00332a054
) / J. Am. Chem. Soc. by W Stec (1984) -
Agrawal, S. et al. Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85, 7079–7083 (1988).
(
10.1073/pnas.85.19.7079
) / Proc. Natl. Acad. Sci. USA by S Agrawal (1988) -
Wickstroms, E.L. et al. Human promyelocitic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide target against c-myc mRNA. Proc. Natl. Acad. Sci. USA 85, 1028–1032 (1988).
(
10.1073/pnas.85.4.1028
) / Proc. Natl. Acad. Sci. USA by EL Wickstroms (1988) - Stein, C.A. et al. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. J. Acq. Imm. Defi. Synd. 4, 686–6939 (1991). / J. Acq. Imm. Defi. Synd. by CA Stein (1991)
-
Yakubov, L.A. et al. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. USA 86, 6454–6458 (1989).
(
10.1073/pnas.86.17.6454
) / Proc. Natl. Acad. Sci. USA by LA Yakubov (1989) -
Leonetti, J.P., Machy, P., Degols, G., Lebleu, B. & Leserman, L. Antibody targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibited viral replication. Proc. Natl. Acad. Sci. USA 87, 2448–2451 (1989).
(
10.1073/pnas.87.7.2448
) / Proc. Natl. Acad. Sci. USA by JP Leonetti (1989) -
Milhaud, P.G., Machy, P., Colote, S., Lebleu, B. & Leserman, L. Free and liposome-encapsulated double-stranded RNAs as inducers of interferon, interleukin-6, and cellular toxicity. J. Interferon Res. 11, 261–265 (1991).
(
10.1089/jir.1991.11.261
) / J. Interferon Res. by PG Milhaud (1991) -
Thierry, A.R. & Dritschilo, A. Intracellular availability unmodified phosphorothioate and liposomally encapsulated oligodeoxyribonucleotides for antisense activity. Nucleic Acids Res. 21, 5691–5698 (1992).
(
10.1093/nar/20.21.5691
) / Nucleic Acids Res. by AR Thierry (1992) -
Hatta, T. et al. Inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by unmodified, phosphorothioated, and liposomally encapsulated oligonucleotides. Biochem. Biophys. Res. Commun. 223, 341–346 (1996).
(
10.1006/bbrc.1996.0896
) / Biochem. Biophys. Res. Commun. by T Hatta (1996) -
Hatta, T., Takai, K., Nakada, S., Yokota, T. & Takaku, H. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells. Biochem. Biophys. Res. Commun. 232, 545–549 (1997).
(
10.1006/bbrc.1997.6185
) / Biochem. Biophys. Res. Commun. by T Hatta (1997) - Bennett, C.F., Chaing, M-Y., Chang, H., Schoemaker, J.E. & Mirabelli, C.K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41, 1023–1033 (1992). / Mol. Pharmacol. by CF Bennett (1992)
-
Stewart, M.J. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum. Gene Ther. 3, 267–275 (1992).
(
10.1089/hum.1992.3.3-267
) / Hum. Gene Ther. by MJ Stewart (1992) -
Keogh, M.-C. High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid-DNA complex. Gene Ther. 4, 162–171 (1997).
(
10.1038/sj.gt.3300374
) / Gene Ther. by M-C Keogh (1997) -
Lewis, J.G. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA 93, 3176–3181 (1996).
(
10.1073/pnas.93.8.3176
) / Proc. Natl. Acad. Sci. USA by JG Lewis (1996) -
Abe, T. et al. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells. Antivir. Chem. Chemother. 9, 253–262 (1998).
(
10.1177/095632029800900306
) / Antivir. Chem. Chemother. by T Abe (1998) -
Yamashita, M., Krystal, M. & Palese, P. Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Virology 171, 458–466 (1989).
(
10.1016/0042-6822(89)90615-6
) / Virology by M Yamashita (1989) -
Jambrina, E., Barcena, J., Uez, O. & Portela, A. The three subunits of the polymerase and the nucleoprotein of influenza B virus are the minimum set of viral proteins required for expression of a model RNA template. Virology 235, 209–217 (1997).
(
10.1006/viro.1997.8682
) / Virology by E Jambrina (1997) -
Agatsuma, T. et al. Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288. Antiviral Res. 34, 121–130 (1997).
(
10.1016/S0166-3542(97)01032-2
) / Antiviral Res. by T Agatsuma (1997) -
Stein, C.A. Does antisense exist?: it may, but only under very special circumstances. Nat. Med. 11, 1119–1121 (1995).
(
10.1038/nm1195-1119
) / Nat. Med. by CA Stein (1995) -
Stein, C.A. & Cheng, Y.-C. Antisense oligonucleotides as therapeutic agents—is the bullet really magical? Science 261,1004–1012 (1993).
(
10.1126/science.8351515
) / Science by CA Stein (1993) -
Stein, C.A. & Krieg, A.M. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Dev. 4, 67–69 (1994).
(
10.1089/ard.1994.4.67
) / Antisense Res. Dev. by CA Stein (1994) -
Wagner, R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature 372, 333–335 (1994).
(
10.1038/372333a0
) / Nature by RW Wagner (1994) -
Davis, H.L. et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870–876 (1998).
(
10.4049/jimmunol.160.2.870
) / J. Immunol. by HL Davis (1998) -
Brazolot Millan, C.L., Weeratna, R., Krieg, A.M., Siegrist, C-A. & Davis, H.L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA 95, 15553–15558 (1998).
(
10.1073/pnas.95.26.15553
) / Proc. Natl. Acad. Sci. USA by CL Brazolot Millan (1998) -
Liu, Y. et al. Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. 270, 24864–24870 (1995).
(
10.1074/jbc.270.42.24864
) / J. Biol. Chem. by Y Liu (1995) -
Zhu, N., Liggitt, D., Liu, Y. & Debs, R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261, 209–211 (1993).
(
10.1126/science.7687073
) / Science by N Zhu (1993) -
Tsan, M.-F., Tsan, G.L. & White, J.E. Surfactant inhibits cationic liposome-mediated gene transfer. Hum. Gene Ther. 8, 817–825 (1997).
(
10.1089/hum.1997.8.7-817
) / Hum. Gene Ther. by M-F Tsan (1997)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 4:48 a.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 4:01 p.m.) |
Indexed | 1 month, 1 week ago (July 30, 2025, 10:13 a.m.) |
Issued | 26 years, 3 months ago (June 1, 1999) |
Published | 26 years, 3 months ago (June 1, 1999) |
Published Print | 26 years, 3 months ago (June 1, 1999) |
@article{Mizuta_1999, title={Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A}, volume={17}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/9893}, DOI={10.1038/9893}, number={6}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Mizuta, Tadashi and Fujiwara, Masatoshi and Hatta, Toshifumi and Abe, Takayuki and Miyano-Kurosaki, Naoko and Shigeta, Shiro and Yokota, Tomoyuki and Takaku, Hiroshi}, year={1999}, month=jun, pages={583–587} }